Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 698

1.

Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time.

Benedetti JK, Zeh J, Corey L.

Ann Intern Med. 1999 Jul 6;131(1):14-20.

PMID:
10391810
2.

Recurrence rates in genital herpes after symptomatic first-episode infection.

Benedetti J, Corey L, Ashley R.

Ann Intern Med. 1994 Dec 1;121(11):847-54.

PMID:
7978697
3.

Natural history of genital herpes simplex virus type 1 infection.

Engelberg R, Carrell D, Krantz E, Corey L, Wald A.

Sex Transm Dis. 2003 Feb;30(2):174-7.

PMID:
12567178
4.

An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.

Fife KH, Warren TJ, Justus SE, Heitman CK; HS2100275 STUDY TEAM..

Sex Transm Dis. 2008 Jul;35(7):668-73. doi: 10.1097/OLQ.0b013e31816d1f42.

PMID:
18461016
5.

Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.

Handsfield HH, Warren T, Werner M, Phillips JA.

Sex Transm Dis. 2007 Jun;34(6):339-43.

PMID:
17065847
6.

Evidence of latency and reactivation of both herpes simplex virus (HSV)-1 and HSV-2 in the genital region.

Sucato G, Wald A, Wakabayashi E, Vieira J, Corey L.

J Infect Dis. 1998 Apr;177(4):1069-72.

PMID:
9534984
7.

Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.

Kim HN, Wald A, Harris J, Almekinder J, Heitman C, Corey L.

Sex Transm Dis. 2008 Feb;35(2):124-8.

PMID:
17921912
8.

Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.

Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, Krieger JN, Corey L.

N Engl J Med. 2000 Mar 23;342(12):844-50.

9.

Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.

Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr.

Infect Dis Obstet Gynecol. 2001;9(2):75-80.

10.

Reducing the risk of transmitting genital herpes: advances in understanding and therapy.

Leone P.

Curr Med Res Opin. 2005 Oct;21(10):1577-82. Review.

PMID:
16238897
11.

Virologic characteristics of subclinical and symptomatic genital herpes infections.

Wald A, Zeh J, Selke S, Ashley RL, Corey L.

N Engl J Med. 1995 Sep 21;333(12):770-5.

12.

Once-daily valacyclovir to reduce the risk of transmission of genital herpes.

Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, Douglas JM Jr, Paavonen J, Morrow RA, Beutner KR, Stratchounsky LS, Mertz G, Keene ON, Watson HA, Tait D, Vargas-Cortes M; Valacyclovir HSV Transmission Study Group..

N Engl J Med. 2004 Jan 1;350(1):11-20.

13.

Prevention of perinatal herpes: prophylactic antiviral therapy?

Scott LL.

Clin Obstet Gynecol. 1999 Mar;42(1):134-48; quiz 174-5. Review.

PMID:
10073307
14.

Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial.

Kimberlin D, Powell D, Gruber W, Diaz P, Arvin A, Kumar M, Jacobs R, Van Dyke R, Burchett S, Soong SJ, Lakeman A, Whitley R.

Pediatr Infect Dis J. 1996 Mar;15(3):247-54.

PMID:
8852914
15.
16.

Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.

Wald A, Zeh J, Barnum G, Davis LG, Corey L.

Ann Intern Med. 1996 Jan 1;124(1 Pt 1):8-15.

PMID:
7503497
17.

Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.

Patel R, Bodsworth NJ, Woolley P, Peters B, Vejlsgaard G, Saari S, Gibb A, Robinson J.

Genitourin Med. 1997 Apr;73(2):105-9.

18.

One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.

Bavaro JB, Drolette L, Koelle DM, Almekinder J, Warren T, Tyring S, Wald A.

Sex Transm Dis. 2008 Apr;35(4):383-6. doi: 10.1097/OLQ.0b013e31815e4190.

PMID:
18362859
19.
20.

Frequency and reactivation of nongenital lesions among patients with genital herpes simplex virus.

Benedetti JK, Zeh J, Selke S, Corey L.

Am J Med. 1995 Mar;98(3):237-42.

PMID:
7872339

Supplemental Content

Support Center